| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1995;60:1563-1572
© 1995 The Society of Thoracic Surgeons
Departments of Thoracic and Cardiovascular Surgery and Biomathematics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
* Address reprint requests to Dr Walsh, Department of Thoracic and Cardiovascular Surgery, M.D. Anderson Cancer Center, Box 109, 1515 Holcombe Blvd, Houston, TX 77030.
Background.: There are no guidelines for the appropriate follow-up of patients after pulmonary resection for lung cancer.
Methods.: Three-hundred fifty-eight consecutive patients who had undergone complete resections of non—small cell lung cancer between 1987 and 1991 were evaluated for tumor recurrence and development of second primary tumors. Recurrences were categorized by site (local or distant), mode of presentation (symptomatic or asymptomatic), treatment given (curative intent or palliative), and duration of overall survival.
Results.: Recurrences developed in 135 patients (local only, 32; local and distant, 13; and distant only, 90). Of these, 102 were symptomatic and 33 were asymptomatic (most diagnosed by screening chest roentgenogram). Forty patients received treatment with curative intent (operation or radiation therapy > 50 Gy) and 95 were treated palliatively. The median survival duration from time of recurrence was 8.0 months for symptomatic patients and 16.6 months for asymptomatic patients (p = 0.008). Multivariate analysis shows that disease-free interval (greater than 12 months or less than or equal to 12 months) was the most important variable in predicting survival after recurrence and that mode of presentation, site of recurrence, initial stage, and histologic type did not significantly affect survival. New primary tumors developed in 35 patients.
Conclusions.: Although detection of asymptomatic recurrences gives a lead time bias of 8 to 10 months, mode of treatment and overall survival duration are not greatly affected by this earlier detection. Disease-free interval appears to be the most important determinant of survival. Screening for asymptomatic recurrences in patients who have had lung cancer is unlikely to be cost-effective. Frequent follow-up and extensive radiologic evaluation of patients after operation for lung cancer are probably unnecessary.
This article has been cited by other articles:
|
|
 |
|
  R. M. Turner, K. J. L. Bell, R. L. Morton, A. Hayen, A. B. Francken, K. Howard, B. Armstrong, J. F. Thompson, and L. Irwig Optimizing the Frequency of Follow-Up Visits for Patients Treated for Localized Primary Cutaneous Melanoma J. Clin. Oncol., December 10, 2011; 29(35): 4641 - 4646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cho and E. B. Lee A follow-up of integrated positron emission tomography/computed tomography after curative resection of non-small-cell lung cancer in asymptomatic patients J. Thorac. Cardiovasc. Surg., June 1, 2010; 139(6): 1447 - 1451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Grunfeld and C. C. Earle The Interface Between Primary and Oncology Specialty Care: Treatment Through Survivorship J Natl Cancer Inst Monographs, April 1, 2010; 2010(40): 25 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-J. Hung, W.-J. Jeng, W.-H. Hsu, K.-J. Wu, T.-Y. Chou, C.-C. Hsieh, M.-H. Huang, J.-S. Liu, and Y.-C. Wu Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis Thorax, March 1, 2010; 65(3): 241 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J-J Hung, W-H Hsu, C-C Hsieh, B-S Huang, M-H Huang, J-S Liu, and Y-C Wu Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence Thorax, March 1, 2009; 64(3): 192 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nakagawa, N. Okumura, K. Ohata, H. Igai, T. Matsuoka, and K. Kameyama Postrecurrence survival in patients with stage I non-small cell lung cancer Eur J Cardiothorac Surg, September 1, 2008; 34(3): 499 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rubins, M. Unger, and G. L. Colice Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent Therapy: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 355S - 367S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sugimura, F. C. Nichols, P. Yang, M. S. Allen, S. D. Cassivi, C. Deschamps, B. A. Williams, and P. C. Pairolero Survival After Recurrent Nonsmall-Cell Lung Cancer After Complete Pulmonary Resection Ann. Thorac. Surg., February 1, 2007; 83(2): 409 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Williams, H. Sugimura, C. Endo, F. C. Nichols, S. D. Cassivi, M. S. Allen, P. C. Pairolero, C. Deschamps, and P. Yang Predicting Postrecurrence Survival Among Completely Resected Nonsmall-Cell Lung Cancer Patients Ann. Thorac. Surg., March 1, 2006; 81(3): 1021 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Kent, P. Korn, J. L. Port, P. C. Lee, N. K. Altorki, and R. J. Korst Cost Effectiveness of Chest Computed Tomography After Lung Cancer Resection: A Decision Analysis Model Ann. Thorac. Surg., October 1, 2005; 80(4): 1215 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Battafarano, S. D. Force, B. F. Meyers, J. Bell, T. J. Guthrie, J. D. Cooper, and G. A. Patterson Benefits of resection for metachronous lung cancer J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 836 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al. American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003 J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353. [Full Text] [PDF]
|
|
|
|
|
|
M. K. Ferguson and A. G. Lehman Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques Ann. Thorac. Surg., December 1, 2003; 76(6): 1782 - 1788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Chiu, M.-S. Chern, M.-H. Wu, W.-H. Hsu, Y.-C. Wu, M.-H. Huang, and S.-C. Chang Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: Preliminary report J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1300 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Colice, J. Rubins, and M. Unger Follow-up and Surveillance of the Lung Cancer Patient Following Curative-Intent Therapy Chest, January 1, 2003; 123(2009): 272S - 283S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Lamont, J. T. Kakuda, D. Smith, L. D. Wagman, and F. W. Grannis Jr Systematic Postoperative Radiologic Follow-up in Patients With Non-Small Cell Lung Cancer for Detecting Second Primary Lung Cancer in Stage IA Arch Surg, August 1, 2002; 137(8): 935 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Benfield Systematic Postoperative Radiologic Follow-up in Patients With Non-Small Cell Lung Cancer for Detecting Second Primary Lung Cancer in Stage IA--Invited Critique Arch Surg, August 1, 2002; 137(8): 940 - 940. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Egermann, K. Jaeggi, J.M. Habicht, A.P. Perruchoud, P. Dalquen, and M. Soler Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Eur. Respir. J., March 1, 2002; 19(3): 464 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Jeremic, Y. Shibamoto, L. Acimovic, N. Nikolic, A. Dagovic, J. Aleksandrovic, and G. Radosavljevic-Asic Second Cancers Occurring in Patients With Early Stage Non-Small-Cell Lung Cancer Treated With Chest Radiation Therapy Alone J. Clin. Oncol., February 15, 2001; 19(4): 1056 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Nguyen, S. Desai, A. Chen, T. S. Weiser, and D. S. Schrump Modulation of metastasis phenotypes of non-small cell lung cancer cells by 17-allylamino 17-demethoxy geldanamycin Ann. Thorac. Surg., December 1, 2000; 70(6): 1853 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Ponn Lightning Can Strike Twice : Second Primary Lung Cancers Chest, December 1, 2000; 118(6): 1526 - 1529. [Full Text] [PDF]
|
|
|
|
|
|
V. Westeel, D. Choma, F. Clement, M.-C. Woronoff-Lemsi, J.-F. Pugin, A. Dubiez, and A. Depierre Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer Ann. Thorac. Surg., October 1, 2000; 70(4): 1185 - 1190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gilbert, K. R. Reid, M. Y. Lam, and D. Petsikas Who should follow up lung cancer patients after operation? Ann. Thorac. Surg., June 1, 2000; 69(6): 1696 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Younes, J. L. Gross, and D. Deheinzelin Follow-up in Lung Cancer: How Often and for What Purpose? Chest, June 1, 1999; 115(6): 1494 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yokoi, N. Kamiya, H. Matsuguma, S. Machida, T. Hirose, K. Mori, and K. Tominaga Detection of Brain Metastasis in Potentially Operable Non-small Cell Lung Cancer: A Comparison of CT and MRI Chest, March 1, 1999; 115(3): 714 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Johnson Second Lung Cancers in Patients After Treatment for an Initial Lung Cancer J Natl Cancer Inst, September 16, 1998; 90(18): 1335 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Hiebert The "Cured" lung cancer patient: Is follow-up by the surgeon worthwhile? Ann. Thorac. Surg., December 1, 1995; 60(6): 1557 - 1558. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
